RxLogix
RxLogix is a pharmacovigilance and drug safety software company that provides cloud-based platforms for adverse event case management, signal detection, risk management, and regulatory reporting to pharmaceutical, biotech, and CRO customers. Its products help life sciences organizations comply with global safety regulations, improve safety operations, and analyze safety data across the drug development and post‑marketing lifecycle. The company generates revenue through software licensing, SaaS subscriptions, and related implementation and support services.
- Industry-Specific ERP
- IT Consulting & Implementation
- Revenue
- $35.0M
- Employees
- 250
- Founded
- 2011
- Headquarters
- Edison, United States of America
What 25 Arbolus experts think of RxLogix
NPS responses are positively skewed: most scores are between 7 and 10, with a minority at 6. Renewal intent is high among major accounts, especially those with significant annual spend and operational maturity; uncertainty or negative renewal intent is seen among few low-spend or pilot users. Stickiness is strong in large, regulated environments where RxLogix is deeply integrated, but complexity and integration limitations dampen enthusiasm for smaller firms. Expert feedback praises compliance strength and analytics but repeatedly notes interface complexity, limited customization, and challenges in interoperability and cost transparency. Overall Customer Sentiment: Positive
Who reviewed RxLogix
- C-Suite 58% (14)
- Director 38% (10)
- Manager 4% (1)
Employer names and spend open in the full report, along with the other 22 customers.
Everything 25 customers told us about RxLogix.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
28 Net Promoter Score, from 25 scored reviews- Promoters 8
- Passives 16
- Detractors 1
Cumulative NPS by month
+0 over 6 months- Dec 8
- Apr 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 6 reviews, accumulated up to each month. Category median 28 across 6 companies.
Praised
- Specialization and User-Friendliness
- Depth of Analytics and FDA Endorsement
- Regulatory Compliance and Audit Readiness
- Customization and Flexible Workflows
Criticised
- AI and Innovation Gaps
- Regulatory and Market Evolution
- Vendor Consolidation Pressure
- Integration Limitations
What customers say
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 64% 14 answers
- 75% 8 answers
- 100% 1 answer
- 0% 1 answer
- 8.5/10 Average score from customers who will renew
- 7.4/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
Top alternatives
Most weighed by RxLogix customers
Report
More in Data & Analytics and Consulting & Professional Services
Other companies in both categories with a customer report.
For people who use RxLogix
Do you use RxLogix at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 25 customers of RxLogix have already contributed
Takes a few minutes. Your identity stays anonymous.